Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm

Faisal Aziz, Helena Kuivaniemi

Research output: Contribution to journalReview article

53 Citations (Scopus)

Abstract

Abdominal aortic aneurysm (AAA) is a significant health problem in the United States, with approximately 30,000 repair operations annually. Treatment of AAA is associated with more than 150,000 hospital admissions per year. The development of AAA is characterized by destruction of the elastic media of the aortic wall. A large body of evidence suggests that a group of enzymes called matrix metalloproteinases (MMPs) plays a significant role in the destruction of extracellular matrix in the aortic wall. MMP inhibition has, therefore, been viewed as an alternative pharmacotherapeutic approach to slow down the development and progression of small AAAs, thus reducing the need for surgical intervention.

Original languageEnglish (US)
Pages (from-to)392-401
Number of pages10
JournalAnnals of Vascular Surgery
Volume21
Issue number3
DOIs
StatePublished - May 1 2007

Fingerprint

Matrix Metalloproteinase Inhibitors
Abdominal Aortic Aneurysm
Matrix Metalloproteinases
Extracellular Matrix
Health
Enzymes

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

@article{caf845ac4ad349aab5b6eb1d996e213c,
title = "Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm",
abstract = "Abdominal aortic aneurysm (AAA) is a significant health problem in the United States, with approximately 30,000 repair operations annually. Treatment of AAA is associated with more than 150,000 hospital admissions per year. The development of AAA is characterized by destruction of the elastic media of the aortic wall. A large body of evidence suggests that a group of enzymes called matrix metalloproteinases (MMPs) plays a significant role in the destruction of extracellular matrix in the aortic wall. MMP inhibition has, therefore, been viewed as an alternative pharmacotherapeutic approach to slow down the development and progression of small AAAs, thus reducing the need for surgical intervention.",
author = "Faisal Aziz and Helena Kuivaniemi",
year = "2007",
month = "5",
day = "1",
doi = "10.1016/j.avsg.2006.11.001",
language = "English (US)",
volume = "21",
pages = "392--401",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",
number = "3",

}

Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm. / Aziz, Faisal; Kuivaniemi, Helena.

In: Annals of Vascular Surgery, Vol. 21, No. 3, 01.05.2007, p. 392-401.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm

AU - Aziz, Faisal

AU - Kuivaniemi, Helena

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Abdominal aortic aneurysm (AAA) is a significant health problem in the United States, with approximately 30,000 repair operations annually. Treatment of AAA is associated with more than 150,000 hospital admissions per year. The development of AAA is characterized by destruction of the elastic media of the aortic wall. A large body of evidence suggests that a group of enzymes called matrix metalloproteinases (MMPs) plays a significant role in the destruction of extracellular matrix in the aortic wall. MMP inhibition has, therefore, been viewed as an alternative pharmacotherapeutic approach to slow down the development and progression of small AAAs, thus reducing the need for surgical intervention.

AB - Abdominal aortic aneurysm (AAA) is a significant health problem in the United States, with approximately 30,000 repair operations annually. Treatment of AAA is associated with more than 150,000 hospital admissions per year. The development of AAA is characterized by destruction of the elastic media of the aortic wall. A large body of evidence suggests that a group of enzymes called matrix metalloproteinases (MMPs) plays a significant role in the destruction of extracellular matrix in the aortic wall. MMP inhibition has, therefore, been viewed as an alternative pharmacotherapeutic approach to slow down the development and progression of small AAAs, thus reducing the need for surgical intervention.

UR - http://www.scopus.com/inward/record.url?scp=34247581734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247581734&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2006.11.001

DO - 10.1016/j.avsg.2006.11.001

M3 - Review article

C2 - 17484978

AN - SCOPUS:34247581734

VL - 21

SP - 392

EP - 401

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 3

ER -